TrialThe Lancet. Haematology2016

Alemtuzumab in T-cell large granular lymphocytic leukaemia: interim results from a single-arm, open-label, phase 2 study.

Bogdan Dumitriu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.